Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response

Bethany Hansen, Anna Sokolovska, Harm HogenEsch, Stanley L. Hem

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Adsorption of the antigen to an aluminum-containing adjuvant is considered an important aspect of vaccine formulation. Adsorption is described by two parameters: the maximum amount that can be adsorbed as a monolayer, which is characterized by the adsorptive capacity and the strength of the adsorption force, which is described by the adsorptive coefficient. Research to date has focused on the adsorptive capacity with the goal of complete adsorption of the antigen. In this study, the relationship between the adsorptive coefficient and immunopotentiation was investigated. Four vaccines were prepared in which the adsorptive coefficient was varied by altering the number of phosphate groups on the antigen (alpha casein and dephosphorylated alpha casein) or the number of surface hydroxyls on the adjuvant (aluminum hydroxide adjuvant and phosphate-treated aluminum hydroxide adjuvant). In vitro elution upon exposure to interstitial fluid or normal human plasma was inversely related to the adsorptive coefficient. The geometric mean antibody titer in mice was also inversely related to the adsorptive coefficient. T-cell activation was not observed in mice that received the vaccine with the greatest adsorptive coefficient (alpha casein/aluminum hydroxide adjuvant). This suggests that antigen processing and presentation to T-cells is impaired when the antigen is adsorbed too strongly.

Original languageEnglish (US)
Pages (from-to)6618-6624
Number of pages7
JournalVaccine
Volume25
Issue number36
DOIs
StatePublished - Sep 4 2007
Externally publishedYes

Fingerprint

Aluminum
Aluminum Hydroxide
Adsorption
adjuvants
aluminum
alpha-casein
adsorption
Caseins
aluminum hydroxide
immune response
antigens
Antigens
Vaccines
Antigen Presentation
vaccines
T-Lymphocytes
T-lymphocytes
phosphates
Extracellular Fluid
extracellular fluids

Keywords

  • Adsorptive coefficient
  • Aluminum hydroxide adjuvant
  • Antigen adsorption
  • Elution
  • Ligand exchange
  • Strength of adsorption
  • T-cell activation

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response. / Hansen, Bethany; Sokolovska, Anna; HogenEsch, Harm; Hem, Stanley L.

In: Vaccine, Vol. 25, No. 36, 04.09.2007, p. 6618-6624.

Research output: Contribution to journalArticle

Hansen, Bethany ; Sokolovska, Anna ; HogenEsch, Harm ; Hem, Stanley L. / Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response. In: Vaccine. 2007 ; Vol. 25, No. 36. pp. 6618-6624.
@article{2e9fc571fe8e4fa0898eda493bf055d9,
title = "Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response",
abstract = "Adsorption of the antigen to an aluminum-containing adjuvant is considered an important aspect of vaccine formulation. Adsorption is described by two parameters: the maximum amount that can be adsorbed as a monolayer, which is characterized by the adsorptive capacity and the strength of the adsorption force, which is described by the adsorptive coefficient. Research to date has focused on the adsorptive capacity with the goal of complete adsorption of the antigen. In this study, the relationship between the adsorptive coefficient and immunopotentiation was investigated. Four vaccines were prepared in which the adsorptive coefficient was varied by altering the number of phosphate groups on the antigen (alpha casein and dephosphorylated alpha casein) or the number of surface hydroxyls on the adjuvant (aluminum hydroxide adjuvant and phosphate-treated aluminum hydroxide adjuvant). In vitro elution upon exposure to interstitial fluid or normal human plasma was inversely related to the adsorptive coefficient. The geometric mean antibody titer in mice was also inversely related to the adsorptive coefficient. T-cell activation was not observed in mice that received the vaccine with the greatest adsorptive coefficient (alpha casein/aluminum hydroxide adjuvant). This suggests that antigen processing and presentation to T-cells is impaired when the antigen is adsorbed too strongly.",
keywords = "Adsorptive coefficient, Aluminum hydroxide adjuvant, Antigen adsorption, Elution, Ligand exchange, Strength of adsorption, T-cell activation",
author = "Bethany Hansen and Anna Sokolovska and Harm HogenEsch and Hem, {Stanley L.}",
year = "2007",
month = "9",
day = "4",
doi = "10.1016/j.vaccine.2007.06.049",
language = "English (US)",
volume = "25",
pages = "6618--6624",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "36",

}

TY - JOUR

T1 - Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response

AU - Hansen, Bethany

AU - Sokolovska, Anna

AU - HogenEsch, Harm

AU - Hem, Stanley L.

PY - 2007/9/4

Y1 - 2007/9/4

N2 - Adsorption of the antigen to an aluminum-containing adjuvant is considered an important aspect of vaccine formulation. Adsorption is described by two parameters: the maximum amount that can be adsorbed as a monolayer, which is characterized by the adsorptive capacity and the strength of the adsorption force, which is described by the adsorptive coefficient. Research to date has focused on the adsorptive capacity with the goal of complete adsorption of the antigen. In this study, the relationship between the adsorptive coefficient and immunopotentiation was investigated. Four vaccines were prepared in which the adsorptive coefficient was varied by altering the number of phosphate groups on the antigen (alpha casein and dephosphorylated alpha casein) or the number of surface hydroxyls on the adjuvant (aluminum hydroxide adjuvant and phosphate-treated aluminum hydroxide adjuvant). In vitro elution upon exposure to interstitial fluid or normal human plasma was inversely related to the adsorptive coefficient. The geometric mean antibody titer in mice was also inversely related to the adsorptive coefficient. T-cell activation was not observed in mice that received the vaccine with the greatest adsorptive coefficient (alpha casein/aluminum hydroxide adjuvant). This suggests that antigen processing and presentation to T-cells is impaired when the antigen is adsorbed too strongly.

AB - Adsorption of the antigen to an aluminum-containing adjuvant is considered an important aspect of vaccine formulation. Adsorption is described by two parameters: the maximum amount that can be adsorbed as a monolayer, which is characterized by the adsorptive capacity and the strength of the adsorption force, which is described by the adsorptive coefficient. Research to date has focused on the adsorptive capacity with the goal of complete adsorption of the antigen. In this study, the relationship between the adsorptive coefficient and immunopotentiation was investigated. Four vaccines were prepared in which the adsorptive coefficient was varied by altering the number of phosphate groups on the antigen (alpha casein and dephosphorylated alpha casein) or the number of surface hydroxyls on the adjuvant (aluminum hydroxide adjuvant and phosphate-treated aluminum hydroxide adjuvant). In vitro elution upon exposure to interstitial fluid or normal human plasma was inversely related to the adsorptive coefficient. The geometric mean antibody titer in mice was also inversely related to the adsorptive coefficient. T-cell activation was not observed in mice that received the vaccine with the greatest adsorptive coefficient (alpha casein/aluminum hydroxide adjuvant). This suggests that antigen processing and presentation to T-cells is impaired when the antigen is adsorbed too strongly.

KW - Adsorptive coefficient

KW - Aluminum hydroxide adjuvant

KW - Antigen adsorption

KW - Elution

KW - Ligand exchange

KW - Strength of adsorption

KW - T-cell activation

UR - http://www.scopus.com/inward/record.url?scp=34547699645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547699645&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2007.06.049

DO - 10.1016/j.vaccine.2007.06.049

M3 - Article

VL - 25

SP - 6618

EP - 6624

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 36

ER -